- Report
- February 2018
- 302 Pages
Global
From €3894EUR$4,050USD£3,341GBP
- Report
- May 2023
- 74 Pages
Global
From €3500EUR$3,899USD£3,108GBP
- Report
- May 2023
- 92 Pages
Global
From €3500EUR$3,899USD£3,108GBP
- Report
- August 2021
- 87 Pages
Global
From €3200EUR$3,565USD£2,841GBP
- Report
- May 2022
- 46 Pages
Global
From €1923EUR$2,000USD£1,650GBP
From €124EUR$129USD£106GBP
- Report
- June 2022
- 230 Pages
Global
From €5547EUR$5,769USD£4,759GBP
- Report
- September 2019
Asia Pacific
From €5163EUR$5,370USD£4,430GBP
- Report
- September 2022
- 274 Pages
Global
From €5510EUR$5,730USD£4,727GBP
- Report
- September 2022
- 200 Pages
Global
From €5510EUR$5,730USD£4,727GBP
- Report
- May 2023
- 140 Pages
Global
From €5768EUR$5,999USD£4,948GBP
- Report
- April 2023
- 147 Pages
Global
From €5768EUR$5,999USD£4,948GBP
- Book
- April 2018
- 312 Pages
- Book
- November 2015
- 776 Pages
- Book
- June 2021
- 464 Pages
- Book
- February 2016
- 1416 Pages
- Book
- August 2015
- 288 Pages
- Book
- April 2013
- 320 Pages
- Book
- November 2011
- 284 Pages
- Book
- March 2008
- 352 Pages
The Stem Cell Transplant market is a subset of the larger stem cell industry. It involves the use of stem cells to treat a variety of diseases and conditions, including cancer, blood disorders, and genetic diseases. Stem cell transplants are used to replace damaged or diseased cells with healthy ones, and can be used to treat a variety of conditions.
The stem cell transplant market is a rapidly growing field, with new treatments and technologies being developed and tested. Companies in the market are focused on developing and commercializing stem cell therapies, as well as providing services related to stem cell transplantation. These companies include Celgene, Novartis, and Osiris Therapeutics. Additionally, there are a number of smaller companies that are focused on developing and commercializing stem cell therapies, such as Athersys, Inc., and Pluristem Therapeutics. Show Less Read more
